Condition: Oncology · Quality of Life · Symptoms and Signs · Sponsor: Institut Rafael
Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.
This description comes directly from the study's public registry record.
Alain TOLEDANO, MD · + 33 (0)1 84 00 70 07 · alain.toledano@horg.fr
Always discuss trial participation with your own doctor first.
| Institute Rafaël | Levallois-Perret, Institut Rafael, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06317714